Lobbying registrant · LD-2 disclosures
Massachusetts Biotechnology Council
Massachusetts
66 filings · 1 client · 7 lobbyists registered · 2008–2026 · latest filed May 4, 2026
Fees billed to clients
$0
never billed a fee — files for itself
Its own lobbying spend
$1.6M
filed on its own behalf
Clients represented
1
7 lobbyists registered
Reported spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who they lobby for
This registrant files only on its own behalf — it has never reported a fee for representing anyone else.
Reported as lobbying expenses
Money reported as spent on lobbying rather than as a fee charged to a client.
What they lobby on
Issue areas declared on the filings, ranked by how many filings name each one.
Medicare/Medicaid
MMM · 1 client
47 filings
$1.3M on those filings
Copyright/Patent/Trademark
CPT · 1 client
45 filings
$900K on those filings
Budget/Appropriations
Who does the lobbying
Every lobbyist named on this registrant's filings.
- John Heffernan68 filings1 client · through 2026
- Robert Coughlin47 filings1 client · through 2020
- Ann JablonCovered position: Chief of Staff, Congressman Richard Neal38 filings1 client · through 2026
- Edward Coppinger14 filings1 client · through 2026
- Kendalle Burlin O'Connell14 filings1 client · through 2026
- Jay Mccarthy
The filings
The 20 most recent of 66 filings. Every figure above is built from these records.
This record groups every filed spelling of the registrant's name into one entity, so punctuation variants of the same firm read as one. The grouping is the registrant's normalized name — firms that file under genuinely different names appear separately. Handle: massachusetts-biotechnology-council.